Morning vs evening dosing of the cathepsin K inhibitor ONO-5334: effects on bone resorption in postmenopausal women in a randomized, phase 1 trial

Por Eastell, R., Dijk, D.-J., Small, M., Greenwood, A., Sharpe, J., Yamada, H., Yuba, M., Tanimoto, M., Deacon, S.
Publicado no Osteoporos Int (2015)

A scalable method for the production of high-titer and high-quality adeno-associated type 9 vectors using the HSV platform

Por Adamson-Small, Laura, Potter, Mark, Falk, Darin J, Cleaver, Brian, Byrne, Barry J, Clément, Nathalie
Publicado no Mol Ther Methods Clin Dev (2016)

Improved Overall Survival Trends of Men with Newly Diagnosed M1 Prostate Cancer: A SWOG Phase III Trial Experience (S8494, S8894 & S9346)

Por Tangen, Catherine M., Hussain, Maha H.A., Higano, Celestia S., Eisenberger, Mario A., Small, Eric J., Wilding, George, Donnelly, Bryan J., Schelhammer, Paul F., Crawford, E. David, Vogelzang, Nicholas J., Powell, Isaac J., Thompson, Ian M.
Publicado em 2012

Loss‐Framed Financial Incentives and Personalized Goal‐Setting to Increase Physical Activity Among Ischemic Heart Disease Patients Using Wearable Devices: The ACTIVE REWARD Randomi...

Por Chokshi, Neel P., Adusumalli, Srinath, Small, Dylan S., Morris, Alexander, Feingold, Jordyn, Ha, Yoonhee P., Lynch, Marta D., Rareshide, Charles A.L., Hilbert, Victoria, Patel, Mitesh S.
Publicado no J Am Heart Assoc (2018)

Activated Lymphocyte Recruitment Into the Tumor Microenvironment Following Preoperative Sipuleucel-T for Localized Prostate Cancer

Por Fong, Lawrence, Carroll, Peter, Weinberg, Vivian, Chan, Stephen, Lewis, Jera, Corman, John, Amling, Christopher L., Stephenson, Robert A., Simko, Jeffrey, Sheikh, Nadeem A., Sims, Robert B., Frohlich, Mark W., Small, Eric J.
Publicado no J Natl Cancer Inst (2014)

Phase III Trial of Prophylactic Cranial Irradiation Compared With Observation in Patients...

Por Sun, Alexander, Bae, Kyounghwa, Gore, Elizabeth M., Movsas, Benjamin, Wong, Stuart J., Meyers, Christina A., Bonner, James A., Schild, Steven E., Gaspar, Laurie E., Bogart, Jeffery A., Werner-Wasik, Maria, Choy, Hak
Publicado em 2011

A phase II study of high dose epirubicin in unresectable non small cell lung cancer.

Por Smit, E. F., Berendsen, H. H., Piers, D. A., Smeets, J., Riva, A., Postmus, P. E.
Publicado em 1992

Endpoints in Phase II trials for advanced non-small cell lung cancer

Por Mandrekar, Sumithra J., Qi, Yingwei, Hillman, Shauna L., Allen Ziegler, Katie L., Reuter, Nicholas F., Rowland, Kendrith M., Kuross, Steven A., Marks, Randolph S., Schild, Steven E., Adjei, Alex A.
Publicado em 2010

Randomized Phase II Study of Gefitinib Compared With Placebo in Chemotherapy-Naive Patients...

Por Goss, Glenwood, Ferry, David, Wierzbicki, Rafal, Laurie, Scott A., Thompson, Joyce, Biesma, Bonne, Hirsch, Fred R., Varella-Garcia, Marileila, Duffield, Emma, Ataman, Ozlem U., Zarenda, Marc, Armour, Alison A.
Publicado no J Clin Oncol (2009)

Combined paclitaxel and gemcitabine as first-line treatment in metastatic non-small cell lung cancer: a multicentre phase II study

Por Douillard, J Y, Lerouge, D, Monnier, A, Bennouna, J, Haller, A M, Sun, X S, Assouline, D, Grau, B, Rivière, A
Publicado em 2001

Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer

Por Paz-Ares, L, Ross, H, O'Brien, M, Riviere, A, Gatzemeier, U, Von Pawel, J, Kaukel, E, Freitag, L, Digel, W, Bischoff, H, García-Campelo, R, Iannotti, N, Reiterer, P, Bover, I, Prendiville, J, Eisenfeld, A J, Oldham, F B, Bandstra, B, Singer, J W, Bonomi, P
Publicado em 2008

Randomized Phase III Trial of Vinorelbine Plus Cisplatin Compared With Observation in Completely...

Por Butts, Charles A., Ding, Keyue, Seymour, Lesley, Twumasi-Ankrah, Philip, Graham, Barbara, Gandara, David, Johnson, David H., Kesler, Kenneth A., Green, Mark, Vincent, Mark, Cormier, Yvon, Goss, Glenwood, Findlay, Brian, Johnston, Michael, Tsao, Ming-Sound, Shepherd, Frances A.
Publicado em 2010

Noncytotoxic suramin as a chemosensitizer in patients with advanced non-small-cell lung cancer: a phase II study

Por Villalona-Calero, M. A., Otterson, G. A., Wientjes, M. G., Weber, F., Bekaii-Saab, T., Young, D., Murgo, A. J., Jensen, R., Yeh, T.-K., Wei, Y., Zhang, Y., Eng, C., Grever, M., Au, J. L.-S.
Publicado em 2008

Alectinib versus chemotherapy in crizotinib-pretreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer: results from the phase III ALUR study

Por Novello, S, Mazières, J, Oh, I -J, de Castro, J, Migliorino, M R, Helland, Å, Dziadziuszko, R, Griesinger, F, Kotb, A, Zeaiter, A, Cardona, A, Balas, B, Johannsdottir, H K, Das-Gupta, A, Wolf, J
Publicado no Ann Oncol (2018)

Mitomycin, ifosfamide and cis-platin in non-small cell lung cancer: treatment good enough to compare.

Por Cullen, M. H., Joshi, R., Chetiyawardana, A. D., Woodroffe, C. M.
Publicado em 1988

Randomized Phase II Trial of Erlotinib Beyond Progression in Advanced Erlotinib-Responsive Non-Small Cell Lung Cancer

Por Halmos, Balazs, Pennell, Nathan A., Fu, Pingfu, Saad, Shumaila, Gadgeel, Shirish, Otterson, Gregory A., Mekhail, Tarek, Snell, Michael, Kuebler, J. Philip, Sharma, Neelesh, Dowlati, Afshin
Publicado no Oncologist (2015)

A Randomized, Phase II, Biomarker-Selected Study Comparing Erlotinib to Erlotinib Intercalated...

Por Hirsch, Fred R., Kabbinavar, Fairooz, Eisen, Tim, Martins, Renato, Schnell, Fredrick M., Dziadziuszko, Rafal, Richardson, Katherine, Richardson, Frank, Wacker, Bret, Sternberg, David W., Rusk, Jason, Franklin, Wilbur A., Varella-Garcia, Marileila, Bunn, Paul A., Camidge, D. Ross
Publicado em 2011

Update on taxanes in the first-line treatment of advanced non-small-cell lung cancer

Por Socinski, M.A.
Publicado em 2014

Second-line treatment with irinotecan plus cisplatin vs cisplatin of patients with advanced non-small-cell lung cancer pretreated with taxanes and gemcitabine: a multicenter randomised phase II study

Por Georgoulias, V, Agelidou, A, Syrigos, K, Rapti, A, Agelidou, M, Nikolakopoulos, J, Polyzos, A, Athanasiadis, A, Tselepatiotis, E, Androulakis, N, Kalbakis, K, Samonis, G, Mavroudis, D
Publicado em 2005

A Randomized Phase II Study to Assess the Efficacy of Pemetrexed or Sunitinib or Pemetrexed Plus...

Por Heist, Rebecca S., Wang, Xiaofei, Hodgson, Lydia, Otterson, Gregory A., Stinchcombe, Thomas E., Gandhi, Leena, Villalona-Calero, Miguel A., Watson, Peter, Vokes, Everett E., Socinski, Mark A.
Publicado no J Thorac Oncol (2014)